» Articles » PMID: 16916557

Intensity Modulated Photon and Proton Therapy for the Treatment of Head and Neck Tumors

Overview
Journal Radiother Oncol
Specialties Oncology
Radiology
Date 2006 Aug 19
PMID 16916557
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: A comparative treatment planning study has been performed between intensity modulated photon and proton therapy to investigate the ability of both modalities to spare organs at risk in the head and neck region while keeping target dose homogeneous. Additional advantage of reducing the spot size for IMPT was also investigated. The treatment planning comparison was extended by varying the number of fields to study its effect on the performance of each modality. Risks of secondary cancer induction were also calculated for all modalities.

Materials And Methods: Five planning CTs were selected for the study. Four different constraints were set to the organs at risk in order to measure the resulting dose homogeneity in the target volume. Five and nine field plans were made for IMXT and 3, 5 and 9 field plans were made for IMPT, for both spot sizes. Dose homogeneity as a function of the mean parotid dose was visualized using a 'pseudo' Pareto-optimal front approach. Risks of secondary cancer were estimated using the organ equivalent dose model.

Results: Critical organs were best spared using 3-field IMPT and, at least for IMPT, little advantage was seen with increasing field numbers. Reducing the spot size does give an advantage. In contrast, there was a significant advantage in going from 5 to 9 fields for IMXT. Secondary cancer risk was lowest for the IMPT plans with reduced spot size, for which normal tissue received the lowest integral dose. Interestingly, although integral dose remained the same, increasing the number of IMPT fields increased the secondary cancer risk, due to the increased volume of tissue irradiated to low dose.

Conclusions: IMPT has a better ability to spare organs at risk than IMXT for the same dose homogeneity. It also significantly reduced the estimated risk of secondary cancer induction and the use of small numbers of fields further increased this advantage. Given that target homogeneity and normal tissue sparing were equally good with the 3 field IMPT, there appears to be a clear rationale to deliver small numbers of fields for IMPT.

Citing Articles

Quantification of beam size impact on intensity-modulated proton therapy with robust optimization in head and neck cancer-comparison with intensity-modulated radiation therapy.

Baba H, Hotta K, Takahashi R, Motegi K, Sugama Y, Sakae T J Radiat Res. 2024; 66(1):65-73.

PMID: 39724929 PMC: 11753836. DOI: 10.1093/jrr/rrae097.


Clinical advantages of incorporating predicted weekly anatomy in IMPT optimization with reduced setup error.

Zhang Y, Chan M Med Phys. 2024; 51(12):9207-9216.

PMID: 39298742 PMC: 11656292. DOI: 10.1002/mp.17412.


Interdisciplinary Collaboration in Head and Neck Cancer Care: Optimizing Oral Health Management for Patients Undergoing Radiation Therapy.

Kutuk T, Atak E, Villa A, Kalman N, Kaiser A Curr Oncol. 2024; 31(4):2092-2108.

PMID: 38668058 PMC: 11049200. DOI: 10.3390/curroncol31040155.


CBCT-Based Dose Monitoring and Adaptive Planning Triggers in Head and Neck PBS Proton Therapy.

Reiners K, Dagan R, Holtzman A, Bryant C, Andersson S, Nilsson R Cancers (Basel). 2023; 15(15).

PMID: 37568697 PMC: 10417147. DOI: 10.3390/cancers15153881.


Design, testing and characterization of a proton central axis alignment device for the dynamic collimation system.

Geoghegan T, Patwardhan K, Ying Q, Nelson N, Yu J, Gutierrez A Biomed Phys Eng Express. 2023; 9(4).

PMID: 37267924 PMC: 10330655. DOI: 10.1088/2057-1976/acdad5.